World's Best Scientists 2026 revealed!
Award Badge
Medicine
Lebanon
2026

D-Index & Metrics

Medicine

D-Index
127
Citations
77975
World Ranking
2785
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Medicine in Lebanon Leader Award
  • 2025 - Research.com Medicine in Lebanon Leader Award
  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Fadlo R. Khuri is affiliated with the American University of Beirut in Lebanon. The primary fields of study in their research encompass Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields such as Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Economics and Econometrics, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in their work include:

  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Economic and Financial Impacts of Cancer
  • Lung Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Advances in Oncology and Radiotherapy
  • RNA modifications and cancer

Among the recent papers authored by Khuri are:

  • "YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype," 2020, Journal of Thoracic Oncology
  • "Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study," 2020, Journal for ImmunoTherapy of Cancer
  • "Systematic discovery of mutation-directed neo-protein-protein interactions in cancer," 2022, Cell
  • "Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer," 2020, Cancer Medicine
  • "Climate Change and Cancer Care: A Policy Statement From ASCO," 2023, JCO Oncology Practice

Frequent co-authors in Khuri's publications include:

  • Taofeek K. Owonikoko
  • Suresh S. Ramalingam
  • Sagar Lonial
  • Zhengjia Chen
  • Shi-Yong Sun

The most common publication venues for Khuri's work are:

  • Cancer
  • Journal of Biological Chemistry
  • Journal of Clinical Oncology
  • Holland-Frei Cancer Medicine
  • Clinical Cancer Research

Khuri has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), an award received in 2014.

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

    Fadlo R. Khuri;John Nemunaitis;Ian Ganly;James Arseneau

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

    Zenggang Li;Andrei A. Ivanov;Rina Su;Valentina Gonzalez-Pecchi

  • Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

    Shi Yong Sun;Laura M. Rosenberg;Xuerong Wang;Zhongmei Zhou

  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.

    André Kahles;Kjong-Van Lehmann;Nora C Toussaint;Matthias Hüser

  • Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

    Taro Hitosugi;Sumin Kang;Matthew G. Vander Heiden;Tae Wook Chung

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

    Robert Haddad;Robert Haddad;Anne O'Neill;Guilherme Rabinowits;Roy Tishler

  • Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

    Alice O. Kamphorst;Rathi N. Pillai;Shu Yang;Tahseen H. Nasti

  • Perspectives for Cancer Prevention With Natural Compounds

    A.R.M. Ruhul Amin;Omer Kucuk;Fadlo R. Khuri;Dong M. Shin

  • Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

    Stephen G. Swisher;Jack A. Roth;John Nemunaitis;David D. Lawrence

  • Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

    J. Nemunaitis;F. Khuri;I. Ganly;J. Arseneau

Frequent Co-Authors

Taofeek K. Owonikoko
Taofeek K. Owonikoko Emory University
Dong M. Shin
Dong M. Shin Emory University
Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Shi-Yong Sun
Shi-Yong Sun Emory University
Waun Ki Hong
Waun Ki Hong The University of Texas MD Anderson Cancer Center
Haian Fu
Haian Fu Emory University
Walter J. Curran
Walter J. Curran Emory University
Sagar Lonial
Sagar Lonial Emory University
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of alternative careers and online degree pathways. For those interested in healthcare leadership, consider the top cahme-accredited mha programs to build advanced management expertise in hospital and health systems administration.

If you are nursing-trained and seeking flexible advancement, there are specialized rn to bsn programs available online, many of which do not require traditional clinical hours. This makes it easier for working nurses to level up their qualifications.

Professionals aiming for the highest levels in nursing might explore short dnp programs, which offer accelerated pathways to the Doctor of Nursing Practice degree. These programs often feature condensed timelines and are designed for those eager to advance quickly.

Additionally, some dnp programs without dissertation eliminate the need for a lengthy dissertation, streamlining the route to a terminal degree in nursing. This flexibility can help you align your educational pathway with your career goals in healthcare.

Best Scientists Citing Fadlo R. Khuri

Trending Scientists

Recently Published Articles